Edited By Indra Spiecker gen. Döhmann and Astrid Wallrabenstein
BrainLinks-BrainTools: Intelligent Neurotechnological Systems for Healthcare (Tonio Ball, Joschka Boedecker, Ilka Diester, Carola Haas,Jürgen Hennig, Christoph Kaller, Christoph Maurer,Oliver Müller, Oliver Paul, Patrick Ruther,Ulrike Wallrabe, Wolfram Burgard)
Tonio Ball, Joschka Boedecker, Ilka Diester, Carola Haas, Jürgen Hennig, Christoph Kaller, Christoph Maurer, Oliver Müller, Oliver Paul, Patrick Ruther, Ulrike Wallrabe, Wolfram Burgard BrainLinks-BrainTools: Intelligent Neurotechnological Systems for Healthcare Intelligent robots, prostheses and implants may contribute greatly to health care by offering better therapy for diseases like epilepsy and Parkinson’s disease and as assistive devices to paralyzed and amputated patients. The authors, researchers of the BrainLinks-BrainTools project, present their approaches and results. Introduction Intelligent robots perceive their environment and autonomously generate actions to achieve their goal. The European Commission has identified intelligent robots as a key technology for personalizing care and boosting the quality, access and efficiency of healthcare. Application domains of intelligent robots include several promising areas, such as smart medical capsules, robot-based surgery, intelligent prosthetics, robot-based motor coordination analysis and therapy, robot-assisted mental, cognitive and social therapy, and robot-based patient monitoring systems. Intelligent robots combined with neurotechnology give rise to the field of intel- ligent neurobotic systems for healthcare. Intelligent neurobotic systems are a central topic of the cluster of excellence BrainLinks-BrainTools at the University of Freiburg. BrainLinks-BrainTools has two visions. First, to develop intelligent assistive devices and prostheses which are connected to the brain of people with paralysis or amputations and that are able to return movement capacity. We refer to this type of device as “Limbs with Neural Control” (LiNC). And second, to develop fully implanted devices with closed-loop feedback for the treatment of neurological disorders, such as epilepsy, Parkinson’s disease, stroke, depression...
You are not authenticated to view the full text of this chapter or article.
This site requires a subscription or purchase to access the full text of books or journals.
Do you have any questions? Contact us.Or login to access all content.